A detailed history of Graham Capital Management, L.P. transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 10,701 shares of CDMO stock, worth $131,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,701
Holding current value
$131,729
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.7 - $12.45 $71,696 - $133,227
10,701 New
10,701 $121,000
Q1 2024

May 15, 2024

SELL
$5.86 - $8.79 $23,522 - $35,283
-4,014 Reduced 26.34%
11,228 $75,000
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $70,722 - $145,713
15,242 New
15,242 $99,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $765M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.